Details for: LOVENOX HP
Company: SANOFI-AVENTIS CANADA INC
DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
---|---|---|---|---|---|
02242692 | LOVENOX HP | ENOXAPARIN SODIUM | 120 MG / 0.8 ML | SOLUTION | SUBCUTANEOUS |
02378469 | LOVENOX HP | ENOXAPARIN SODIUM | 150 MG / ML | SOLUTION | SUBCUTANEOUS |
Summary Reports
Regulatory Decision Summary
Summary Safety Review - Low-Molecular-Weight Heparins - Assessing the potential risk of bleeding in or around the spinal cord (Spinal/Epidural Hematoma)
Summary Safety Review - Low-Molecular-Weight Heparins - Assessing the potential risk of bleeding in or around the spinal cord (Spinal/Epidural Hematoma)
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.